| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $95.7M | — | -8.1% |
| Cost of Revenue | $60.5M | — | -4.1% |
| Gross Profit | $35.2M | — | -14.3% |
| R&D Expense | $2.4M | — | -0.2% |
| SG&A Expense | $18.0M | — | +24.5% |
| Operating Income | -$16.8M | — | -16.3% |
| Pre-tax Income | -$30.5M | — | -59.6% |
| Income Tax | $47K | — | +14.6% |
| Net Income | -$30.5M | — | -59.6% |
| EPS (Basic) | -$0.28 | — | -255.6% |
| EPS (Diluted) | -$0.28 | — | -255.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.0M | +2.5% | +15.4% |
| Accounts Receivable | $21.1M | -48.8% | -13.3% |
| Inventory | $58.1M | -2.7% | -3.5% |
| Current Assets | $115.6M | -15.5% | +1.9% |
| Total Assets | $272.0M | -8.2% | -7.4% |
| Current Liabilities | $93.2M | -8.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.0M | — | +113.0% |
| Capital Expenditures | $1.6M | — | -28.1% |
| Investing Cash Flow | -$2.0M | — | +5.2% |
| Financing Cash Flow | -$346K | — | -101.9% |
| Free Cash Flow | $1.4M | — | +105.4% |
| +11.5% |
| Total Liabilities | $332.1M | +1.9% | +13.6% |
| Stockholders' Equity | -$60.1M | -102.5% | -4586.8% |